User:Wxu68/Into Neuroscience-Dr. Potter/Wen Xu

This page is edited by Wen Xu

Estrogen and Neurodegenerative Diseases

One thing links estrogen and neurodegenerative diseases together is known as the Estrogen Replacement Therapy. It is reported that females and males suffer different risk of different types of diseases which cannot set aside neurodegenerative diseases. Discovered the sexual difference in people suffering such diseases, scientists found the thing that really mattered was estrogen, the well known female hormone. Estrogen was found to have many effective aspects of neurodegenerative diseases but can not be a treatment for many reasons. The most important side effect is its ability to higher the chances of getting other diseases such as breast cancer and coronary heart disease. Since estrogen is a large family of molecules that can result in a different function to human, systems for screening such molecules were developed. Also, scientists discovered ways to make their own estrogen-like compounds that can perfectly avoid most side effects used synthetic biochemistry to discover new molecules.

Introduction
Estrogen is a kind of lipid hormones in human which has comparative activity and can regulate many physiological processes. Estrogen is known as the female sex hormone and is largely related to menstrual and estrous. Its biological function is mediated by two receptors: Estrogen Receptor alpha(ERα ) and Estrogen Receptor beta(ERβ ). The two receptors are tissue specific and have different influences on their downstream genes. Decrease of estrogen could lead to many diseases like osteoporosis. Estrogen could work on many genes to regulate physiological activities and low estrogen concentration might lead to a series of cognitive diseases. Estrogen can be divided into four classes:

Animal Estrogens

In this family, three main members in woman are estrone (E1), estradiol (E2), and estriol (E3). Estradiol is the most dominant and studied one among them.

Plant Estrogens (Phytoestrogens)

Produced by plants. These estrogens can cause estrogenic effects by people consuming them. They are structurally similar to estradiol.

Fungi Estrogens (mycoestrogens)

Produced by fungi. It can also affect the human estrogen level by consuming them.

Synthetic Estrogens (xenoestrogens)

A large number of compounds that are synthesized or naturally existed. These estrogens imitate estrogen structural and can be designed to satisfy the need of new drugs. But they may also cause serious problems so they need to be used carefully.

Medical Application
The application of estrogen on medicine can be divided into a number of aspects. The most well know ones are breast cancer and coronary heart disease. Estrogen also plays very important role in animal metabolism balance. These main diseases caused by Estrogen have a relationship with neurodegenerative diseases since human hormone balance has a wide range of influence on all sides.

Breast Cancer
Breast cancer is a type of cancer originating from breast tissue, most commonly from the inner lining of milk ducts or the lobules that supply the ducts with milk. Cancers originating from ducts are known as ductal carcinomas, while those originating from lobules are known as lobular carcinomas. Breast cancer occurs in humans and other mammals. While the overwhelming majority of human cases occurs in women, male breast cancer can also occur.

Estrogen and breast cancer
For breast cancer patients, endocrine therapy with selective estrogen receptor modulators (SERMs) to suppress the growth of estradiol sensitive breast tumors. But it has also been hypothesized that higher levels of endogenous hormones increase the risk of breast cancer. The most prevalent idea is estrogen's carcinogenic effect on breast cancer. The involvement of estrogen-receptor-mediated signaling leads to the production of reactive metabolites that may exert genotoxic effects.

Coronary artery disease
Coronary artery disease (CAD) is a kind of disease that has plaque building up along the inner walls of the coronary arteries and narrows the arteries then reduces blood flow to the heart to affect oxygen supplement to heart muscles. The main causes of coronary heart disease mainly include: age, sex, family history, smoking, high levels of certain fats and cholesterol in the blood, high blood pressure, high levels of sugar in the blood due to insulin resistance or diabetes and blood vessel inflammation.

Estrogen and coronary heart diseases
The Framingham study found out that cardiovascular risk is accentuated for women in particular and many following studies have documented worsened cardiac outcomes for women. Since estrogen has strong regulation of common intracellular signaling pathways in the maintenance of cardiomyocyte function and underlying aspects of female cardiovascular pathophysiology, estrogen can have great influence on coronary heart diseases.

Introduction
Neurodegenerative diseases are diseases caused along the process of neurodegeneration. Neurodegeneration includes structural and functional loss of neurons or even the death of the neurons. The causes of such diseases can be various but can be concluded into four aspects: genetic mutation, protein misfolding, intracellular mechanisms and programmed cell death.

Alzheimer's Disease
Alzheimer's disease(AD) is the most common form of dementia. There are many common symptoms of this disease although it is developed differently in every individual. In the early stages, patients often suffer difficulty in remembering recent events. As the disease advances, symptoms can include confusion, irritability, aggression, mood swings, trouble with language, and long-term memory loss. Gradually, bodily functions are lost, ultimately leading to death.

Parkinson's Disease
Parkinson's disease(PD) is a neurodegenerative disorder of the central nervous system. The motor symptoms of Parkinson's disease result from the death of dopamine-generating cells in the substantia nigra, a region of the midbrain while the cause of this cell death is unknown.

Huntington's Disease
Huntington's disease (HD) is a neurodegenerative genetic disorder that affects muscle coordination and leads to cognitive decline and psychiatric problems. HD causes astrogliosis and loss of medium spiny neurons.

Amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is a debilitating disease with varied etiology characterized by rapidly progressive weakness, muscle atrophy and fasciculations, muscle spasticity, difficulty speaking (dysarthria), difficulty swallowing (dysphagia), and difficulty breathing (dyspnea).

Efforts Made on Therapy
Different neurodegenerative diseases have different causes and are not well studied until now. There is no clear cure for such diseases but some efforts have been made to research deeper into them. The 10th Global College of Neuroproetction and Neuroregeneration Annual Conference together with the International Association of Neurorestoratology VI was held to discuss on neurorestoration, neuroprotection and neuroregeneration in various clinical neurodegenerative diseases like Alzheimer's, Parkinson's, Huntington's disease, stroke and brain or spinal cord injuries. The main aim was to enhance health care by the use of stem cells, nanodrug delivery of drugs and stem cells, use of multimodal drugs as well as a combination of different approaches. They concluded that the future of neuroprotection could be achieved by the use of stem cells and nanodrug delivery in chronic neurological disorders.

Estrogen and neurodegenerative diseases
Although estrogen is best known for its effects on the maturation and differentiation of the primary and secondary sex organs, increasing evidence suggests that its influence extends beyond this system, and its activity in the CNS may initiate, or influence our susceptibility to neurodegenerative decline. Estrogen has been proposed to act as a neuroprotectant at several levels, and it is probable that deprivation of estrogen as a result of menopause exposes the aging or diseased brain to several insults. In addition, estrogen deprivation is likely to initiate or enhance degenerative changes caused by oxidative stress, and to reduce the brain's ability to maintain synaptic connectivity and cholinergic integrity leading to the cognitive decline seen in aged and disease-afflicted individuals. There is sufficient evidence that estradiol is a powerful neuroprotectant which might have use against not only AD, but also stroke and Parkinson’s disease, both in women and men, and the development of better estrogen derivatives should be considered a priority.

Estrogen and Alzheimer's disease
Neurofibrillary tangles formed by amyloid-β (Aβ) deposition and amyloid plaques formed by tau protein phosphorylation are dominant physiological features of Alzheimer's disease. Amyloid precursor protein (APP) proteolysis is fundamental for production of Aβ peptides implicated in AD pathology. By using a cell line that contains high levels of estrogen receptors, scientists found that treatment with physiological concentrations of 17 beta-estradiol is associated with accumulation in the conditioned medium of an amino-terminal cleavage product of APP (soluble APP or protease nexin-2), indicative of non-amyloidogenic processing.

Estrogen and Parkinson's disease
Estrogen deprivation leads to the death of dopamine cells in the brain that could have implications for post-menopausal women, but the majority of clinical reports support an antidopaminergic effect of estrogens on Parkinsonian symptoms. So recommendations on the use of postmenopausal hormonal replacement therapy in women with Parkinson's disease or those genetically at risk. But another group of scientists found a positive association between estrogen use and lower symptom severity in women with early PD not yet taking L-dopa.

Estrogen and Huntington's disease
Huntington's disease (HD) is a polyglutamine disorder based on an expanded CAG triplet repeat leading to cerebral and striatal neurodegeneration. Potential sex differences concerning the age of onset and the course of the disease are poorly defined, as difficulties of matching female and male HD patients regarding their CAG repeat lengths limit comparability.

Estrogen and Amyotrophic lateral sclerosis
ALS occurs more commonly in men than in women, and women get the disease later in life compared to men. This suggest the possible protective role of estrogen in ALS. By conducting treatment of 17β-estradiol to ovariectomy treated mice, scientists found significantly delay of disease progression.

Introduction
Estrogen Replacement Therapy is a kind of hormone replacement therapy. Its goal is to mitigate discomfort caused by diminished circulating estrogen in menopause. The 2002 Women's Health Initiative of the National Institutes of Health found disparate results for all cause mortality with hormone replacement, finding it to be lower when HRT was begun earlier, between age 50-59, but higher when begun after age 60. In older patients, there was an increased incidence of breast cancer, heart attacks and stroke, although a reduced incidence of colorectal cancer and bone fracture. Some of the WHI findings were again found in a larger national study done in the UK, known as The Million Women Study. As a result of these findings, the number of women taking hormone treatment dropped precipitously. The Women's Health Initiative recommended that women with non-surgical menopause take the lowest feasible dose of HRT for the shortest possible time to minimize associated risks.

Main Pathways
The role of estrogens is mostly mediated by two nuclear receptors (ER alpha and ER beta) and a membrane-associated G-protein (GPR30 or GPER), and it is not limited to reproduction, but it extends to the skeletal, cardiovascular and central nervous systems. Various pathologies such as cancer, inflammatory, neurodegenerative and metabolic diseases are often associated with dysfunctions of the estrogen system. Therapeutic interventions by agents that affect the estrogen signaling pathway might be useful in the treatment of many dissimilar diseases.

Application
The receptors of estrogen are specially distributed in different tissues, which have different influence on their downstream genes. The activation of the two different estrogen receptors have different effects on human. ERα and ERβ also mediate Selective estrogen-receptor modulators’ (SERMs’) function, but the selective ERα agitator can always cause some side effects such as breast cancer or endometrial hyperplasia, while the selective ERβ agitator may play an active effect on such diseases. So, the selective ERβ agitator has more clinical value for neurodegenerative diseases. In post-menopausal women, high levels of testosterone and estrogen higher the risk 2-3 times than lower level situation. Women that are not taking hormone replacement therapy (HRT) have lesser risk of breast cancer because of the insulin level increase.

Introduction
Nonsteroidal estrogens include xenoestrogens, phytoestrogens and mycoestrogens. They are very useful in neurodegenerative diseases' therapy when considering about the side effects caused by estradiol. As the development of chemical synthesis, it becomes more and more possible for people to construct new molecules as they like. The fact that an extremely large number of naturally occurring compounds, and an unlimited number of synthetic compounds, have an estrogen-like activity has been exploited by the drug companies to produce patented proprietary drugs, especially the contraceptives. Phytoestrogens are plant derived estrogens and have similar structures with 17beta-estradiol thus may cause estrogenic or anti-estrogenic effects. Mycoestrogens are produced by fungi and are commonly found in stored grain.

Application
Nonsteroidal estrogens prevalently exist in our environment and have both positive and negative effects on our daily life. But as a possible way to get access to neurodegenerative disease treatment, scientists have developed multiple ways to screen these estrogens and select the ones that have less side effects. Bipartite recombinant yeast system and dual fluorescence report system are designed to screen these potential chemicals.